Related Experiment Videos
Prenatal prediction of Werdnig-Hoffmann disease using linked polymorphic DNA probes
J Melki1, S Abdelhak, P Burlet
1Unité de Recherches sur les Handicaps Génétiques de l'Enfant, INSERM U-12, Hôpital des Enfants-Malades, Paris, France.
Journal of Medical Genetics
|March 1, 1992
Summary
Prenatal diagnosis for Werdnig-Hoffmann disease is now feasible. Genetic analysis can identify affected fetuses in at-risk families, enabling informed decisions for families facing this severe neuromuscular disorder.
Area of Science:
- Genetics
- Neuromuscular Disorders
- Medical Diagnostics
Background:
- Werdnig-Hoffmann disease is a severe, autosomal recessive neuromuscular disorder causing paralysis and death.
- Currently, no treatments exist to prevent or alter the disease's progression.
- Genetic mutations responsible for Werdnig-Hoffmann disease have been localized to chromosome 5q12-q14.
Purpose of the Study:
- To assess the feasibility of prenatal diagnosis for Werdnig-Hoffmann disease.
- To provide genetic analysis for families at risk of Werdnig-Hoffmann disease.
Main Methods:
- Genetic analysis using DNA probes.
- Prenatal diagnosis in at-risk pregnancies.
Main Results:
- Prenatal diagnosis was successfully performed in seven at-risk families.
- Two fetuses were diagnosed with Werdnig-Hoffmann disease.
- Diagnoses were confirmed postnatally.
Conclusions:
- Prenatal diagnosis of Werdnig-Hoffmann disease is achievable.
- Genetic testing offers a viable option for at-risk families.